Genmab A/S (GMAB)

Genmab Revenue

Genmab had revenue of $715.00M in the quarter ending March 31, 2025, with 18.57% growth. This brings the company's revenue in the last twelve months to $3.23B, up 25.43% year-over-year. In the year 2024, Genmab had annual revenue of $2.99B with 22.32% growth.

• Revenue (ttm): $3.23B
• Revenue Growth: +25.43%
• P/S Ratio: 3.64
• Revenue / Employee: $1,359,762
• Employees: 2,682
• Market Cap: 13.28B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.99B	545.24M	22.32%
Dec 31, 2023	2.44B	358.99M	17.23%
Dec 31, 2022	2.08B	796.62M	61.88%
Dec 31, 2021	1.29B	-374.23M	-22.52%
Dec 31, 2020	1.66B	855.79M	106.20%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.